Brief: ClearPoint Neuro Enrolls First Patient in Glioblastoma Trial Using Prism Neuro Laser Therapy System
12/12/2022 15:42
Dec 12 (Reuters) - Clearpoint Neuro Inc CLPT.O :
* CLEARPOINT NEURO ANNOUNCES FIRST PATIENT ENROLLED IN
GLIOBLASTOMA TRIAL USING CLEARPOINT PRISM™ NEURO LASER THERAPY
SYSTEM AT SKÅNE UNIVERSITY HOSPITAL IN SWEDEN
Source text for Eikon: ID:nGNX6WbLvN
Further company coverage: CLPT.O
((Reuters.Briefs@thomsonreuters.com;))